AYTU financials
Aytu BioPharma (AYTU) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- AYTU revenue was $57.57M in fiscal 2026, net income -$14.25M.
AYTU income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $57.57M | $36.82M | -$8.31M | -$14.25M | -1.16 |
| 2025 | $66.38M | $45.83M | -$7.83M | -$13.56M | -2.16 |
| 2024 | $65.18M | $49.05M | -$1.59M | -$15.84M | -2.86 |
| 2023 | $107.40M | $66.63M | -$17.07M | -$17.05M | -5.11 |
| 2022 | $96.67M | $52.28M | -$109.91M | -$108.78M | -74.01 |
| 2021 | $65.63M | $29.20M | -$58.87M | -$58.29M | -69.60 |